Xcout Intel
Sensei Biotherapeutics, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Sensei Biotherapeutics, Inc. among biotech companies — ranked by similarity to what Sensei Biotherapeutics, Inc. actually does, not by market-cap band.
Subscribe to see Sensei Biotherapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Sensei Biotherapeutics, Inc.
Sensei Biotherapeutics, Inc. is a clinical stage biotechnology company focused on the discovery and development of new therapies.
Sensei Biotherapeutics, Inc. at a glance
Sensei Biotherapeutics, Inc. is a biotech company headquartered in United States. It is publicly listed (SNSE) with a market capitalisation of $18.6M. Xcout tracks 14 named people at Sensei Biotherapeutics, Inc., including Christopher Gerry (President, General Counsel, Secretary & Director). Xcout recorded 16 job postings from Sensei Biotherapeutics, Inc. in the last 90 days.
Sensei Biotherapeutics, Inc. leadership
- Christopher GerryPresident, General Counsel, Secretary & Director
- Anand ParikhCOO & Director
- Josiah CraverSenior Vice President of Finance, Principal Financial Officer & Principal Accounting Officer
- Anand ParikhCo-founder of Faeth Therapeutics and new Chief Operating Off
- Lora PikeVice President of Investor Relations & Communications
- Anand Kiran ParikhExecutive Officer
8 more named people on record for Sensei Biotherapeutics, Inc., with roles, board committees and tenure — see the full roster →
Hiring at Sensei Biotherapeutics, Inc.
Xcout recorded 16 job postings from Sensei Biotherapeutics, Inc. in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Sensei Biotherapeutics, Inc.'s hiring signals →
Top 12 Sensei Biotherapeutics, Inc. competitors
Ranked by semantic similarity — how close each company is to Sensei Biotherapeutics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Implicit Bioscience, Inc. is a biotechnology company founded in 2002 that focuses on the clinical development of novel immunotherapies and treatments for critical illnesses.
Biotechnology
Lassen Therapeutics is a biotechnology research company based in San Diego, California, focused on developing novel, best-in-class biotherapeutics to treat patients with serious diseases.
Biotechnology
BreStem Therapeutics, Inc. is a clinical-stage biotechnology company located in Raleigh, North Carolina, focused on developing novel therapeutics to fight various diseases.
Similar biotech company
OSE Immunotherapeutics is a clinical-stage biotechnology company that develops innovative immunotherapies for immune activation and regulation in immuno-oncology and immuno-inflammation. The company utilizes proprietary research platforms and a portfolio of clinical-stage assets to provide therapeutic options for patients.
Biotechnology
Immune Design Corp. is a clinical-stage immunotherapy company with offices in Seattle, Washington, and South San Francisco, California, specializing in novel drug discovery and treatment technologies.
Biotechnology
Sante Veritas Therapeutics Inc is a biotechnology company that develops FGL2-based diagnostic and therapeutic technologies. The company serves patients and researchers by targeting autoimmune diseases, transplant rejection, bacterial and viral infections, and cancer.
Biotechnology
Hookipa Pharma Inc. is a clinical-stage biotechnology company developing immunotherapies and vaccines based on arenavirus vectors, designed to stimulate targeted T-cell and antibody responses. Its programs have focused on cancer and infectious diseases, serving patients through potential therapeutic and preventive treatments.
Biotechnology
Creative BioTherapeutics is a biotechnology company that designs first-in-class biologic therapies, notably its lead candidate CBT300, targeting drug-resistant cancers and late-stage viral diseases. The company serves the healthcare and pharmaceutical research sectors by developing non-toxic treatments intended to reverse drug resistance and immune evasion in oncology and infectious diseases.
Biotechnology
Silverback Therapeutics, Inc. is a biopharmaceutical company focused on leveraging its proprietary ImmunoTAC technology platform to develop therapeutic products.
Biotechnology
BioEclipse Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in California. The company is focused on researching and developing a novel generation of targeted immunotherapies and treatments for oncology.
Biotechnology
Eureka Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing transformative technology platforms and first-in-class T-cell therapies to access cancer-specific targets.
Biotechnology
Soteria Biotherapeutics, Inc. is a biopharmaceutical company founded in 2018 and headquartered in San Francisco, California, specializing in biopharmaceutical advancements and drug pipelines.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Sensei Biotherapeutics, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Sensei Biotherapeutics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →